Dolby Laboratories, Inc. (DLB) Files Form 4 Insider Selling : Roger S Siboni Sells 13,921 Shares

Dolby Laboratories, Inc. (DLB): Roger S Siboni , director of Dolby Laboratories, Inc. sold 13,921 shares on May 12, 2016. The Insider selling transaction was reported by the company on May 16, 2016 to the Securities and Exchange Commission. The shares were sold at $45.44 per share for a total value of $632,600.88 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on May 13, 2016, Dagmar Dolby (10% owner) sold 100 shares at $41.43 per share price.On May 2, 2016, Kevin J Yeaman (President and CEO) sold 51,230 shares at $46.56 per share price.Also, On Feb 4, 2016, N William Jr Jasper (director) sold 7,759 shares at $35.49 per share price.On Feb 4, 2016, Nicholas Jr Donatiello (director) sold 3,880 shares at $35.50 per share price.

Dolby Laboratories: On Friday, May 13, 2016 heightened volatility was witnessed in Dolby Laboratories which led to swings in the share price. The shares opened for trading at $45.31 and hit $45.92 on the upside , eventually ending the session at $45.55, with a gain of 0.09% or 0.04 points. The heightened volatility saw the trading volume jump to 2,52,572 shares. The 52-week high of the share price is $48.7 and the company has a market cap of $4,567 M . The 52-week low of the share price is at $29.87.

Dolby Laboratories Money Flow Index Chart

Company has been under the radar of several Street Analysts.Dolby Laboratories is Reiterated by Dougherty & Company to Buy and the brokerage firm has raised the Price Target to $ 54 from a previous price target of $46 .The Rating was issued on Apr 28, 2016.Dolby Laboratories is Reiterated by Dougherty & Company to Buy and the brokerage firm has raised the Price Target to $ 46 from a previous price target of $38 .The Rating was issued on Apr 25, 2016.Dolby Laboratories is Downgraded by JP Morgan to Neutral. Earlier the firm had a rating of Overweight on the company shares. The Rating was issued on Apr 8, 2016.Dolby Laboratories is Reiterated by Dougherty & Company to Buy and the brokerage firm has raised the Price Target to $ 46 from a previous price target of $38 .The Rating was issued on Mar 28, 2016.

Dolby Laboratories Inc. (Dolby Laboratories) creates audio imaging and communication technologies that transform entertainment and communications at the cinema at home at work and on mobile devices. The Company licenses its audio technologies and also develops technologies aimed at enhancing voice conferencing communications and imaging. Additionally the Company provides products and services that enable entertainment content creators and distributors to produce encode transmit and playback content for consumer experiences. The Company designs and manufactures audio and imaging products for the film production cinema and television broadcast industries. Distributed in approximately 80 countries these products are used in content creation distribution and playback to enhance image and sound quality and improve transmission and playback.

Leave a Reply

Dolby Laboratories - Is it time to Sell?

Top Brokerage Firms are advising their investors on Dolby Laboratories. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.